Other OTC USD

Rennova Health, Inc. (RNVA)

0.0001 0.0000 (0.00%)
At close: April 22 at 2:10 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
20,302.6890
13,036.1720
3,223.8960
7,200.1200
Cost of Revenue
7,491.8020
6,767.9210
5,292.4300
11,783.5260
Gross Profit
12,810.8870
6,268.2510
-2,068.5340
-4,583.4060
Operating Expense
9,165.4370
7,677.7850
8,151.1640
12,361.8920
Operating Income
3,645.4500
-1,409.5340
-10,219.6980
-16,945.2980
Net Non Operating Interest Income Expense
-1,956.3400
-2,257.5440
-3,185.8280
-9,840.7240
Other Income Expense
1,322.5640
705.3470
8,312.6830
7,834.1350
Pretax Income
3,011.6740
-2,961.7310
-5,092.8430
-18,951.8870
Tax Provision
645.3250
312.8490
179.5300
-1,308.1800
Net Income Common Stockholders
2,355.0220
-334,169.4240
-500,871.8500
-281,594.4920
Diluted NI Available to Com Stockholders
2,355.0220
-334,169.4240
-500,871.8500
-281,594.4920
Basic EPS
0.05
-0.03
-913.37
-93.86M
Diluted EPS
0.05
-0.03
-913.37
-93.86M
Basic Average Shares
29,671,259.3000
9,992,238.4680
548.3770
0.0030
Diluted Average Shares
384,187,214.7000
9,992,238.4680
548.3770
0.0030
Total Operating Income as Reported
3,645.4500
-1,409.5340
-12,520.5240
-17,195.2980
Total Expenses
16,657.2390
14,445.7060
13,443.5940
24,145.4180
Net Income from Continuing & Discontinued Operation
2,355.0220
-3,293.0550
5,605.1570
-18,339.7740
Normalized Income
2,082.5783
-3,437.0561
-7,415.9735
-19,936.4351
Interest Expense
1,956.3400
2,257.5440
3,185.8280
9,840.7240
Net Interest Income
-1,956.3400
-2,257.5440
-3,185.8280
-9,840.7240
EBIT
4,968.0140
-704.1870
-1,907.0150
-9,111.1630
EBITDA
5,336.1920
-234.8160
-1,263.4640
-8,410.1700
Reconciled Cost of Revenue
7,491.8020
6,767.9210
5,292.4300
11,783.5260
Reconciled Depreciation
368.1780
469.3710
643.5510
700.9930
Net Income from Continuing Operation Net Minority Interest
2,375.6350
-3,274.5800
-5,272.3730
-17,643.7070
Total Unusual Items Excluding Goodwill
372.9760
205.6660
2,936.4390
2,462.6510
Total Unusual Items
372.9760
205.6660
2,936.4390
2,462.6510
Normalized EBITDA
4,963.2160
-440.4820
-4,199.9030
-10,872.8210
Tax Rate for Calcs
0.0002
0.0002
0.0003
0.0001
Tax Effect of Unusual Items
79.9193
43.1899
792.8385
169.9229
12/31/2020 - 10/19/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RSHN RushNet, Inc.
0.0003
0.00%
 
LMDXF LumiraDx Limited
0.0163
-18.75%
 
IDXG Interpace Biosciences, Inc.
1.4500
0.00%
 
IZOZF Izotropic Corporation
0.1000
0.00%
 
ISPC iSpecimen Inc.
0.3400
+18.06%
 
TTOO T2 Biosystems, Inc.
3.1600
+6.76%
 
WAT Waters Corporation
299.23
+1.06%
 
NEO NeoGenomics, Inc.
13.42
-0.81%
 
NVTAQ Invitae Corporation
0.0031
+106.67%
 
LH Laboratory Corporation of America Holdings
203.07
+0.79%